Skip to main content

Crystallization Development

 Developing a robust crystallization process to isolate the optimal solid form of an API is an essential step in API development. Identifying the crystallization approach, solvent system(s), controlling form, crystal habit and delivering a consistent uniform PSD from a single process step can be very challenging.

Applying expertise in, solid state, PAT and computational modelling all underpin our development of crystallization processes, allowing us to deliver the best outcome at the required scale. We also work on remediating existing crystallizations, which can have a variety of issues such as oiling out, isolating the wrong polymorphic form or just long filtration times.

Understanding the crystallization behaviour of a molecule can help:

  • Maximise process yields
  • Improve purity
  • Control form, morphology and particle size distribution
  • Create processes suitable for transfer and scale-up
  • Strengthen IP
Man in crystallization development lab

The key to controlled, growth-dominated crystallization is a thorough understanding of the solubility and metastable zone width (MSZW) of the system in combination with knowledge of the nucleation and growth kinetics. Once this understanding is acquired by experimental techniques, PAT and modeling, the process can be optimized to target crystal growth and avoid unwanted nucleation events (route 2).

 

Pictorial representation of different crystallization pathways with respect to solubility and MSZWPictorial representation of different crystallization pathways with respect to solubility and MSZW

 

The arrival of advanced high-resolution PAT such as the BlazeMetrics™ probe gives previously unattainable insights into both existing and novel crystallization processes. A combination of high-resolution microscopy and Raman spectroscopy allows the formation and growth of transient forms to be pinpointed and the materials identified in situ.

Raman spectroscopy of a polymorphic transition

 

In situ imaging of a polymorphic transition

In situ Raman spectroscopy and imaging of a polymorphic transition from a metastable form with rhombohedral morphology to a stable form with fibrous morphology.

Through advanced characterization tools, our experienced team of scientists are able to examine crystallization systems at reduced scales. Chord length measurements and in situ images can be used to validate crystal growth models at a small scale. Breakage, aggregation, and secondary nucleation can all be assessed throughout the scale-up process and these events are factored into predictive models during method transfer from vessel to vessel.

Our experts are trained not only in the art of crystallization, but also in solid form science, modeling, PAT, and particle sizing.

Popular posts from this blog

Vera Pharmaceuticals

 

Quality, Compliance and Regulatory Affairs

  We foster a culture of quality and continuous improvement that not only meets the expectations of regulators and customers, but also enables business and provides a competitive advantage. Verapharma quality organization is functionally independent from manufacturing operations, safeguarding unbiased quality decisions. In addition to local quality units, we have a global quality organization that provides governance and guidance to the local quality units, and partners with all relevant functions across the organization to foster a culture in which quality is affirmed as a business enabler and a source of competitive advantage. Our GMP manufacturing sites operate in compliance with applicable regulations, local laws and international guidelines adopted by the various Health Authorities. Compliance at Verapharma is continuously monitored through regulatory inspections conducted by Health Authorities, including FDA and MHRA, quality system audits conducted by our customers, as well ...